SpaceX Stock Is Sliding. Should You Buy the Dip?

SpaceX, which raised more than $85 billion in a record IPO at a $1 trillion valuation, trades about 14% below its $135 IPO price and 3% below its $150 opening price. Its AI unit spent $15 billion on quarterly capex—up from $7 billion sequentially—while generating just $2 billion of revenue; company-wide revenue was $7.8 billion and losses deepened. Upcoming Starship Flight 14 on Sept. 28 is intended to reach Earth orbit and deploy Starlink V3 satellites, but the article argues that risk-averse investors should wait for further evidence that heavy AI investment converts into growth.

Analysis

SPCX is being valued as a vertically integrated option on launch economics, broadband infrastructure and AI compute, but the near-term valuation driver is likely financing capacity rather than operating leverage. AI capex running at a multiple of segment revenue implies negative incremental free cash flow for several quarters; unless Starlink cash generation or external project financing absorbs the burden, equity dilution and a higher cost of capital become the binding constraints. The key underwriting question is not whether orbital compute is technically feasible, but whether it produces a delivered-cost advantage versus terrestrial hyperscale capacity after launch cadence, power, cooling, depreciation and satellite replacement costs.

NVDA is a second-order beneficiary if SPCX continues procuring accelerated compute, but its exposure is economically immaterial relative with broader hyperscaler demand. More relevant is a read-through to satellite and launch supply chains: credible progress toward rapid reuse would pressure competing launch economics while reducing the capital intensity of expanding Starlink capacity; failure would instead strand capacity plans and force SPCX to prioritize its existing connectivity franchise over speculative AI deployment.

The next 1-3 months are event-driven around mission execution and any evidence that satellite deployment translates into monetizable subscriber growth rather than higher network capex. Over 6-18 months, the equity needs AI revenue growth to materially outpace capex growth and a demonstrable decline in launch cost per delivered kilogram to justify a premium platform multiple. Consensus appears too willing to capitalize all growth spend as strategic infrastructure; a missed launch milestone, flat Starlink ARPU, or another step-up in capex without contracted AI revenue would likely trigger multiple compression before fundamentals can recover.

Key Decisions for Investors

• Do not initiate a core SPCX long until two reporting periods establish that AI revenue growth is accelerating while AI capex/revenue is stabilizing; this is a watch item, not a dip-buy signal. Falsifier for caution: disclosed contracted AI backlog or external financing that funds incremental buildout without recourse to common equity.
• For tactical exposure, buy SPCX only following a successful orbital/reuse milestone and hold for 1-3 months, with a stop below the IPO reference level of $135. Target a return toward the initial post-listing range; risk/reward is unattractive ahead of the event given execution-gap downside.
• Express the financing-risk view with a defined-risk SPCX put spread, 3-6 months out, rather than an outright short. The thesis is invalidated by capex guidance falling materially, AI bookings becoming visible, or a non-dilutive funding vehicle for satellite/compute assets.
• Maintain NVDA exposure independently of SPCX: incremental demand from one customer is not thesis-changing, but SPCX procurement commentary is a useful alternative-data signal for AI infrastructure demand. Avoid treating a SPCX setback as a reason to reduce NVDA absent corroborating hyperscaler capex revisions.